MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Compugen Company Profile (NASDAQ:CGEN)

Consensus Ratings for Compugen (NASDAQ:CGEN) (?)
Ratings Breakdown: 6 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $11.67 (74.65% upside)

Analysts' Ratings History for Compugen (NASDAQ:CGEN)
Show:
DateFirmActionRatingPrice TargetActions
6/22/2016FBR & Co.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/9/2016JPMorgan Chase & Co.Lower Price TargetMarket Outperform$14.00 -> $11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/9/2016JMP SecuritiesLower Price TargetMarket Outperform$14.00 -> $11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2016Jefferies GroupReiterated RatingBuy$11.00 -> $9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/1/2016OppenheimerReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/5/2015MLV & Co.Reiterated RatingBuy$14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/27/2014 forward)
Earnings History for Compugen (NASDAQ:CGEN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
2/9/2016Q415($0.11)($0.01)$3.33 million$8.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/3/2015Q315($0.15)($0.13)$1.15 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2015Q215($0.14)($0.14)$1.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2015Q115($0.13)($0.12)$1.48 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/10/2015Q414($0.11)($0.03)$3.70 million$6.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2014Q314($0.11)($0.11)$1.90 million$1.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2014Q214($0.11)($0.05)$1.85 million$2.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/19/2014Q114($0.10)($0.04)$0.16 million$2.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/11/2014Q413($0.09)$0.13 million$1.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2013Q313($0.12)$0.11 million$1.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2012Q312($0.10)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Compugen (NASDAQ:CGEN)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.15)($0.13)($0.14)
Q2 20161($0.17)($0.17)($0.17)
Q3 20161($0.17)($0.17)($0.17)
Q4 20161($0.17)($0.17)($0.17)
(Data provided by Zacks Investment Research)
Dividend History for Compugen (NASDAQ:CGEN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Compugen (NASDAQ:CGEN)
No insider trades for this company have been tracked by MarketBeat.com

Latest Headlines for Compugen (NASDAQ:CGEN)
DateHeadline
06/22/16 08:29 PMForm 6-K COMPUGEN LTD For: Jun 22
06/22/16 03:20 PMCompugen Names Lead Therapeutic Candidate For CGEN-15029 Immuno-Oncology Program IND filing For COM701 ... - Benzinga
06/22/16 09:00 AMCompugen Names Lead Therapeutic Candidate For CGEN-15029 Immuno-Oncology Program IND filing For COM701 Anticipated in 2017 -
06/22/16 07:08 AMCompugen Ltd. breached its 50 day moving average in a Bullish Manner : CGEN-US : June 22, 2016 -
06/22/16 06:39 AMCompugen Discloses Lead Therapeutic Candidate for CGEN-15029 Immuno-Oncology Program - [at noodls] - bedafc9a-6240-40c0-84a2-305f207c3622.pdf FOR IMMEDIATE RELEASE IND filing for COM701 anticipated next year Holon, Israel - June 22, 2016 - Compugen Ltd. (NASDAQ: CGEN), a leading predictive therapeutic ...
06/19/16 03:02 PMWill Compugen Ltd. (NASDAQ:CGEN) Surprise This Quarter? - Investor Newswire
06/19/16 03:02 PMThis Weeks Broker Views For Compugen Ltd. (CGEN) - Fiscal Standard
06/15/16 06:39 AMCompugen to Present at JMP Securities Life Sciences Conference in New York - [at noodls] - 3f544505-39b9-43ba-b7a7-b58258e514bb.pdf FOR IMMEDIATE RELEASE Holon, Israel - June 15, 2016 - Compugen Ltd. (NASDAQ: CGEN), a leading predictive drug discovery company, today announced that Ari Krashin, ...
06/10/16 07:20 AMCompugen Ltd. breached its 50 day moving average in a Bearish Manner : CGEN-US : June 10, 2016 -
06/06/16 07:30 AMBrokers Issue Forecasts for Compugen Ltd.'s FY2017 Earnings (CGEN) - Let Me Know About This
06/03/16 09:16 PMCompugen Ltd. (NASDAQ:CGEN) Stock Update & Estimates - Stock Tick Tock
06/01/16 09:20 PMCompugen Limited (NASDAQ:CGEN) Shorted Shares Increased By 0.37% - HNN - Compugen Limited (NASDAQ:CGEN) Shorted Shares Increased By 0.37%HNNThe stock of Compugen Limited (NASDAQ:CGEN) registered an increase of 0.37% in short interest. CGEN's total short interest was 1.60M shares in June as published by FINRA. Its up 0.37% from 1.59 million shares, reported previously. With 128,900 shares ...
05/31/16 08:37 AMTarget Check and Stock Performance Recap Compugen Ltd. (NASDAQ:CGEN) - HNN - Target Check and Stock Performance Recap Compugen Ltd. (NASDAQ:CGEN)HNNTracking stock performance from various views may help with share evaluation. Some investors might be more focused on short-term share action while others may prefer to view long-term performance. In recent session activity, Compugen Ltd.and more »
05/31/16 08:37 AMStock Review and Earnings Check on Compugen Ltd. (NASDAQ:CGEN) - HNN - Stock Review and Earnings Check on Compugen Ltd. (NASDAQ:CGEN)HNNInvestors and analysts are typically super focused on company earnings numbers when they are reported. Company earnings are a good way to evaluate the company profitability. Currently, sell-side analysts are expecting Compugen Ltd. (NASDAQ:CGEN) ...and more »
05/30/16 10:04 AMNext Weeks Broker Price Targets For Compugen Ltd. (CGEN) - Share Trading News - Next Weeks Broker Price Targets For Compugen Ltd. (CGEN)Share Trading NewsCompugen Ltd. has a 50 day moving average of 6.77 and a 200 day moving average of 6.10. The stock's market capitalization is 345.78M, it has a 52-week low of 4.32 and a 52-week high of 7.98. The share price of the company (CGEN) was up +0.15%, with ...and more »
05/27/16 06:47 PMCompugen Ltd. (CGEN) Updated Price Targets - FTSE News - Compugen Ltd. (CGEN) Updated Price TargetsFTSE NewsCompugen Ltd. has a 50 day moving average of 6.77 and a 200 day moving average of 6.10. The stock's market capitalization is 345.27M, it has a 52-week low of 4.32 and a 52-week high of 7.98. The share price of the company (CGEN) was down -2.57%, ...and more »
05/26/16 05:00 AM'Mad Money' Lightning Round: I'm Buying Buffett's Berkshire Hathaway -
05/25/16 06:28 PMStock Rating Review for Compugen Ltd. (NASDAQ:CGEN) - Wall Street Hints and News - Stock Rating Review for Compugen Ltd. (NASDAQ:CGEN)Wall Street Hints and NewsCovering equity analysts presently have a consensus stock rating of 1 on shares of Compugen Ltd. (NASDAQ:CGEN). Covering analysts will often provide Sell, Hold, or Buy recommendations based on their advanced research. This consensus rating is ...and more »
05/25/16 06:28 PMCompugen Ltd. (NASDAQ:CGEN) Impact Score At 100 - Stocks Daily - Compugen Ltd. (NASDAQ:CGEN) Impact Score At 100Stocks DailyAlpha One explored various online articles released on Compugen Ltd. (NASDAQ:CGEN), and it set a daily sentiment score of 0 on the company. The entity has an algorithm in place to know stock sentiment on the share after exploring the content issued on ...and more »
05/24/16 10:29 AMEarnings Review and Stock Rundown for Compugen Ltd. (NASDAQ:CGEN) - Wall Street Hints and News - Earnings Review and Stock Rundown for Compugen Ltd. (NASDAQ:CGEN)Wall Street Hints and NewsInvestors and analysts will be paying close attention when the company posts earnings results. Earnings numbers can provide insight into a company's overall profitability. Covering equity analysts are expecting Compugen Ltd. (NASDAQ:CGEN) to post ...and more »
05/23/16 06:31 PMTarget Check and Stock Performance Recap Compugen Ltd. (NASDAQ:CGEN) - Wall Street Hints and News - Target Check and Stock Performance Recap Compugen Ltd. (NASDAQ:CGEN)Wall Street Hints and NewsIn recent session activity, Compugen Ltd. (NASDAQ:CGEN) shares have traded +0.88%. Monitoring the stock price relative to moving averages may provide enhanced perspective on share performance. After a recent check, the stock has been recorded ...and more »
05/23/16 03:55 PMETF’s with exposure to Compugen Ltd. : May 23, 2016 -
05/23/16 06:16 AMCompugen to Present at the Jefferies Global Healthcare Conference in New York - [at noodls] - 8c7f6c0e-dbd3-4dba-92d0-c92220c7f618.pdf FOR IMMEDIATE RELEASE Holon, Israel - May 23, 2016 - Compugen Ltd. (NASDAQ: CGEN), a leading predictive drug discovery company, today announced that Ari Krashin, ...
05/22/16 11:14 AMCompugen Ltd. (NASDAQ:CGEN) Comprehensive Income At $0.421 - RealistInvestor.com - Compugen Ltd. (NASDAQ:CGEN) Comprehensive Income At $0.421RealistInvestor.comFor the year ended 2015-12-31, Compugen Ltd. (NASDAQ:CGEN)comprehensive income was $0.421 millions whereas for the quarter ended 2015-12-31, it was $0.421 millions. Compugen Ltd. (NASDAQ:CGEN) posted $-20.163 millions on combined net ...
05/20/16 11:36 PMRevenue Update on Compugen Ltd. (USA)(NASDAQ:CGEN) - Trade Calls - Revenue Update on Compugen Ltd. (USA)(NASDAQ:CGEN)Trade CallsCompugen Ltd. (USA)(NASDAQ:CGEN) announced the earnings results for Fiscal Year 2016 and Q1. The results came in during Pre-market on May 10, 2016. Company reported revenue of $93.00K. Analysts estimated a revenue of $640.00K. Earnings per ...Compugen Ltd. (CGEN) Updated Broker Price TargetsShare Trading NewsCompugen Limited (NASDAQ:CGEN) Shorted Shares Decreased By 7.82%Franklin IndependentMorning Buzz: Compugen Ltd. (NASDAQ:CGEN), Trio-Tech International (NYSEMKT:TRT), Lantronix, Inc. (NASDAQ ...Benchmark Monitorall 4 news articles »
05/18/16 10:50 AMBroker Roundup For Compugen Ltd. (CGEN) - Share Trading News - Broker Roundup For Compugen Ltd. (CGEN)Share Trading News08/05/2015 – Compugen Ltd. had its “buy” rating reiterated by analysts at MLV & Co. They now have a USD 14 price target on the stock. 05/06/2015 – Compugen Ltd. was downgraded to “sell” by analysts at Zacks. The share price of Compugen Ltd. (CGEN) ...and more »
05/16/16 07:42 AMCompugen to Present at the Oppenheimer Annual Israeli Conference in Tel Aviv - [at noodls] - 6594cb84-c2a4-41f0-b4cd-37be5fe21955.pdf FOR IMMEDIATE RELEASE Holon, Israel - May 16, 2016 - Compugen Ltd. (NASDAQ: CGEN), a leading predictive drug discovery company, today announced that Ari Krashin, ...
05/16/16 03:01 AMCompugen Ltd. :CGEN-IL: Earnings Analysis: Q1, 2016 By the Numbers : May 16, 2016 -
05/12/16 11:24 AMCompugen Ltd. :CGEN-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/10/16 06:51 PMCompugen : Steven Holtzman Joins Compugen as Strategic Business Advisor - Compugen Ltd. (NASDAQ: CGEN [http://finance.yahoo.com/q?s=cgen ]), a leading predictive drug discovery company, announced today that Steven Holtzman, former Executive Vice President, Corporate Development of Biogen, has joined Compugen as a strategic ...
05/10/16 08:08 AMSteven Holtzman Joins Compugen as Strategic Business Advisor - [at noodls] - b2a0002b-38d7-462e-9fc9-a4e4488d80ba.pdf FOR IMMEDIATE RELEASE Holon, Israel - May 10, 2016 - Compugen Ltd. (NASDAQ: CGEN), a leading predictive drug discovery company, announced today that Steven Holtzman, ...
05/10/16 07:48 AMCompugen Ltd. Reports First Quarter 2016 Financial Results - [at noodls] - c69efef6-7723-4587-88ba-4a9f681c1cf3.pdf FOR IMMEDIATE RELEASE Holon, Israel, May 10, 2016 - Compugen Ltd. (NASDAQ: CGEN), a leading predictive drug discovery company, today reported financial results ...
05/10/16 06:14 AMCompugen reports 1Q loss -
05/10/16 05:00 AMCompugen Limited (NASDAQ:CGEN) Shorted Shares Decreased By 4.6% - B.O.D.Y Confidential - Compugen Limited (NASDAQ:CGEN) Shorted Shares Decreased By 4.6%B.O.D.Y ConfidentialThe stock of Compugen Limited (NASDAQ:CGEN) registered a decrease of 4.6% in short interest. CGEN's total short interest was 1.73 million shares in May as published by FINRA. Its down 4.6% from 1.81 million shares, reported previously. With 116,300 ...
05/09/16 12:15 AMAfter Last Week What Do Analysts Think Of Compugen Ltd. (CGEN) - Share Trading News - After Last Week What Do Analysts Think Of Compugen Ltd. (CGEN)Share Trading News08/05/2015 – Compugen Ltd. had its “buy” rating reiterated by analysts at MLV & Co. They now have a USD 14 price target on the stock. 05/06/2015 – Compugen Ltd. was downgraded to “sell” by analysts at Zacks. The share price of Compugen Ltd. (CGEN) ...
05/07/16 11:25 PMCompugen Ltd. (NASDAQ:CGEN) Comprehensive Income At $1.222 Millions For Quarter Closed 2014-12-31 - RealistInvestor.com - Compugen Ltd. (NASDAQ:CGEN) Comprehensive Income At $1.222 Millions For Quarter Closed 2014-12-31RealistInvestor.comFor the year ended 2014-12-31, Compugen Ltd. (NASDAQ:CGEN) comprehensive income was $1.222 millions whereas for the quarter ended 2014-12-31, the comprehensive income was $1.222 millions. Compugen Ltd. (NASDAQ:CGEN) posted $-20.163 ...
05/05/16 05:03 AMCompugen Ltd. (CGEN) Updated Broker Price Targets - Share Trading News - Compugen Ltd. (CGEN) Updated Broker Price TargetsShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Compugen Ltd. (CGEN). The latest reports which are currently in issue on Thursday 5th of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts ...
05/02/16 01:12 AMBroker Outlook For The Week Ahead: Compugen Ltd. (CGEN) - Share Trading News - Broker Outlook For The Week Ahead: Compugen Ltd. (CGEN)Share Trading News08/05/2015 – Compugen Ltd. had its “buy” rating reiterated by analysts at MLV & Co. They now have a USD 14 price target on the stock. 05/06/2015 – Compugen Ltd. was downgraded to “sell” by analysts at Zacks. The share price of Compugen Ltd. (CGEN) ...
04/30/16 06:43 PMCompugen Ltd. (NASDAQ:CGEN) EBITDA Yearly Stands At $-20.233 Millions - RealistInvestor.com - Compugen Ltd. (NASDAQ:CGEN) EBITDA Yearly Stands At $-20.233 MillionsRealistInvestor.comFor the period ended 2015-12-31, Compugen Ltd. (NASDAQ:CGEN) comprehensive income was $0.421 millions. For the three-month closed 2015-12-31, the comprehensive income was $0.421 millions. Compugen Ltd. (NASDAQ:CGEN) posted $-20.163 ...Compugen Limited (NASDAQ:CGEN) Sellers Covered 4.6% of Their ShortsThe PostCompugen Ltd. (NASDAQ:CGEN) Wall Street Rating in FocusNews Tribuneall 3 news articles »
04/27/16 09:45 AMCompugen First Quarter 2016 Conference Call and Webcast Scheduled for Tuesday, May 10, 2016 at 10:00 AM ET - [at noodls] - NOT FOR IMMEDIATE RELEASE FOR IMMEDIATE RELEASE Holon, Israel, April 27, 2016 --- Compugen Ltd. (NASDAQ: CGEN), a leading predictive drug discovery company, today announced that the Company will host a ...
04/27/16 01:26 AMCompugen Ltd. (NASDAQ:CGEN) Share Rating Recap - B.O.D.Y Confidential - Compugen Ltd. (NASDAQ:CGEN) Share Rating RecapB.O.D.Y ConfidentialShares of Compugen Ltd. (NASDAQ:CGEN) are tracked by analysts as well as crowd investors. Research from Beta Systems keeps track of crowd sourced sentiment and provides consensus stock ratings. The rating information comes mainly from financial ...and more »
04/26/16 06:56 PMCompugen Ltd. (CGEN) Analyst Review - Risers & Fallers - Compugen Ltd. (CGEN) Analyst ReviewRisers & FallersA number of investment brokers have recently updated their price targets on shares of Compugen Ltd. (CGEN). According to the latest broker reports outstanding on Tuesday 26th of April, 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 ...
04/25/16 08:53 PMCompugen Limited (NASDAQ:CGEN) Sellers Covered 0.43% of Their Shorts - CCH Daily News - Compugen Limited (NASDAQ:CGEN) Sellers Covered 0.43% of Their ShortsCCH Daily NewsThe stock of Compugen Limited (NASDAQ:CGEN) registered a decrease of 0.43% in short interest. CGEN's total short interest was 1.81M shares in April as published by FINRA. Its down 0.43% from 1.82M shares, reported previously. With 111,600 shares ...
04/24/16 07:58 PMCompugen Ltd. (CGEN) Broker Price Targets For The Coming Week - Share Trading News - Compugen Ltd. (CGEN) Broker Price Targets For The Coming WeekShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Compugen Ltd. (CGEN). The latest reports which are currently in issue on Sunday 24th of April state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 ...and more »
04/22/16 07:13 PMCompugen Ltd. (NASDAQ:CGEN) Analyst Rating Review - B.O.D.Y Confidential - Compugen Ltd. (NASDAQ:CGEN) Analyst Rating ReviewB.O.D.Y ConfidentialCovering analysts typically give Buy, Sell and Hold recommendations along with guidance and company earnings projections. Currently, there are 3 analysts that have provided ratings for Compugen Ltd. (NASDAQ:CGEN). 3 have rated the stock a “Strong ...and more »
04/21/16 07:10 PMCompugen Ltd. (NASDAQ:CGEN) Share Rating Recap - The Post - Compugen Ltd. (NASDAQ:CGEN) Share Rating RecapThe PostShares of Compugen Ltd. (NASDAQ:CGEN) are tracked by analysts as well as crowd investors. Research from Beta Systems keeps track of crowd sourced sentiment and provides consensus stock ratings. The rating information comes mainly from financial ...and more »
04/20/16 07:05 PMCompugen Ltd. (CGEN) Updated Broker Ratings - Risers & Fallers - Compugen Ltd. (CGEN) Updated Broker RatingsRisers & FallersA number of investment brokers have recently updated their price targets on shares of Compugen Ltd. (CGEN). According to the latest broker reports outstanding on Wednesday 20th of April, 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 ...
04/19/16 07:26 PMCompugen Ltd. (NASDAQ:CGEN) Reported Comprehensive Income Of $0.421 - Stocks Daily - Compugen Ltd. (NASDAQ:CGEN) Reported Comprehensive Income Of $0.421Stocks DailyFor the period ended 2015–1-2-31, Compugen Ltd. (NASDAQ:CGEN) posted comprehensive income of $0.421 millions. The comprehensive income for the three-month ended 2015–1-2-31 was $0.421 millions. Compugen Ltd. (NASDAQ:CGEN) posted ...Compugen Ltd. (NASDAQ:CGEN) Checking on EarningsFranklin Independentall 2 news articles »
04/07/16 01:48 PMDr. Elliott Sigal Joins Compugen Ltd. as Strategic Advisor and Prof. Drew Pardoll Appointed Director at Compugen USA, Inc. - [at noodls] - 4a2e27db-8bf5-49c3-8338-caeaf21c23a6.pdf For Immediate Release Holon, Israel - April 6, 2016 - Compugen Ltd. (NASDAQ: CGEN), a leading predictive drug discovery company, announced today that Elliott Sigal, ...
03/28/16 08:01 AMCompugen to Present at the Jefferies Immuno-Oncology Summit in Boston - [at noodls] - 97a1fea3-81fb-4851-9e25-ca611b6e6c59.pdf FOR IMMEDIATE RELEASE Holon, Israel - March 28, 2016 - Compugen Ltd. (NASDAQ: CGEN), a leading predictive drug discovery company, today announced that Anat Cohen-Dayag, ...
About Compugen

Compugen logoCompugen Ltd. (Compugen) is a therapeutic discovery company. The Company focuses on the discovery and development of monoclonal antibodies (mAbs) and therapeutic proteins in the fields of oncology and immunology. Its pipeline program consists of drug targets and therapeutic product candidates at various stages ranging from target validation to pre-clinical studies in the fields of oncology and immunology, with a primary focus on immuno-oncology. The Company's therapeutic proteins for immunology include CGEN-15001T, CGEN-15022, CGEN-15029, CGEN-15049 and CGEN-15092, which are based on B7/CD28-like immune checkpoint candidates. It offers various infrastructure platforms, which include LEADS, MED and LINKS, which integrates its scientific understandings and predictive models. It offers various target discovery platforms, which include Antibody-Drug Conjugate Cancer Therapy Discovery Platform, Other Discovery Approaches for Immunomodulatory Proteins and Biomarker Discovery Approaches.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CGEN
  • CUSIP:
Key Metrics:
  • Previous Close: $7.00
  • 50 Day Moving Average: $6.75
  • 200 Day Moving Average: $6.03
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $338.18M
  • Current Quarter EPS Consensus Estimate: $-0.67 EPS
Additional Links:
Compugen (NASDAQ:CGEN) Chart for Monday, June, 27, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha